| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of SELLAS Life Sciences Gr (NASDAQ:SLS) through any online brokerage.
Other companies in SELLAS Life Sciences Gr’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
SELLAS Life Sciences Gr has a consensus price target of $6.50.
The stock price for SELLAS Life Sciences Gr (NASDAQ: SLS) is $11.86 last updated October 12, 2026 at 1:51 PM EDT.
There are no upcoming dividends for SELLAS Life Sciences Gr.
SELLAS Life Sciences Gr does not have any upcoming earnings scheduled.
There is no upcoming split for SELLAS Life Sciences Gr.
SELLAS Life Sciences Gr is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
